Metflux Sciences

MetFlux builds structured systems physiology models and translational infrastructure designed to connect biological mechanisms to precision health systems. The company employs an integrated modeling architecture known as OmeX, which encodes physiological structure across biological scales to enable mechanistic reasoning over transitions rather than simple diagnostic outputs. By applying engineering systems principles to biological phenomena, MetFlux bridges the gap between genotype and phenotype, facilitating complex data interpretation across wellness and disease states.

This technology provides critical value to partners in the nutraceutical, biopharma, and medical nutrition sectors by supporting evidence-backed product development, clinical translation, and endpoint strategy. The company's intelligence platform, MetSights, integrates multi-modal data—including genomics, microbiome, metabolomics, clinical markers, and wearable signals—into actionable physiological insights. Through these efforts, MetFlux enables personalized care workflows and accelerates R&D innovation, helping enterprises move toward predictive and preventive health solutions backed by systems biology.